Ellevest, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Ellevest, Inc.

$1.8 Billion
Q3 2024

A detailed history of Ellevest, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ellevest, Inc. holds 340 shares of REGN stock, worth $253,130. This represents 0.02% of its overall portfolio holdings.

Number of Shares

340

Previous 307 10.75%

Holding current value

$253,130

Previous $322,000 10.87%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $33,794 - $39,658	33 Added 10.75%	340 $357,000
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $5,299 - $6,427	-6 Reduced 1.92%	307 $322,000
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $3,610 - $3,973	4 Added 1.29%	313 $301,000
Q4 2023 Feb 06, 2024	SELL	$775.18 - $881.7 $58,138 - $66,127	-75 Reduced 19.53%	309 $271,000
Q3 2023 Nov 09, 2023	SELL	$692.45 - $844.37 $160,648 - $195,893	-232 Reduced 37.66%	384 $316,000
Q2 2023 Aug 09, 2023	BUY	$700.03 - $830.35 $88,903 - $105,454	127 Added 25.97%	616 $442,000
Q1 2023 May 04, 2023	BUY	$680.49 - $826.97 $55,119 - $66,984	81 Added 19.85%	489 $401,000
Q4 2022 Feb 03, 2023	BUY	$705.89 - $766.39 $7,764 - $8,430	11 Added 2.77%	408 $294,000
Q3 2022 Nov 02, 2022	SELL	$573.97 - $724.32 $24,680 - $31,145	-43 Reduced 9.77%	397 $273,000
Q2 2022 Jul 18, 2022	BUY	$548.35 - $738.84 $3,290 - $4,433	6 Added 1.38%	440 $260,000
Q1 2022 Apr 19, 2022	BUY	$595.12 - $698.43 $123,189 - $144,575	207 Added 91.19%	434 $303,000
Q4 2021 Jan 24, 2022	BUY	$543.48 - $670.97 $543 - $670	1 Added 0.44%	227 $143,000
Q3 2021 Oct 19, 2021	BUY	$574.03 - $680.96 $18,942 - $22,471	33 Added 17.1%	226 $137,000
Q2 2021 Jul 13, 2021	BUY	$472.8 - $558.54 $84,158 - $99,420	178 Added 1186.67%	193 $108,000
Q1 2021 May 03, 2021	SELL	$446.73 - $548.2 $78,177 - $95,935	-175 Reduced 92.11%	15 $7,000
Q4 2020 Feb 04, 2021	BUY	$478.3 - $607.98 $18,175 - $23,103	38 Added 25.0%	190 $92,000
Q3 2020 Oct 26, 2020	SELL	$544.75 - $658.21 $2,179 - $2,632	-4 Reduced 2.56%	152 $85,000
Q2 2020 Jul 06, 2020	BUY	$493.32 - $643.92 $62,651 - $81,777	127 Added 437.93%	156 $97,000
Q1 2020 Apr 13, 2020	BUY	$336.18 - $494.43 $6,051 - $8,899	18 Added 163.64%	29 $14,000
Q4 2019 Feb 05, 2020	BUY	$274.13 - $376.51 $548 - $753	2 Added 22.22%	11 $4,000
Q3 2019 Oct 08, 2019	BUY	$273.46 - $318.39 $2,461 - $2,865	9 New	9 $2,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Account